To uncover tumor suppressors in human HCC, a genome‐wide CRISPR/Cas9‐based screening of primary human hepatocytes with MYC and TP53R249S overexpression (MT‐PHHs) is performed in xenografts. Here, MYC is linked to neoplasm.